Hyderabad: A new line of therapy to treat HIV-1 infection developed by a team at the University of Hyderabad has been granted a patent. The therapy called Novel anti-HIV-1 heteroaromatic compounds targeted to HIV-1 associated Topoisomerase II beta kinase is the discovery of a new compound and has been accomplished through the efforts made by […]
